Secuenciación en cáncer de mama avanzado HER2+ - page 18

Cleopatra: Updated PFS
Investigator-Assessed
26
ITT population. Stratified by geographic region and neo/adjuvant chemotherapy.
n at risk
0
6
37
87
121
179
284
402
0
6
21
51
75
110
223
406
Ptz + T + D
Pla + T + D
0
0
0
10
20
30
40
50
60
70
80
90
100
PFS (%)
0
10
20
30
40
50
80
60
Time (months)
70
Ptz + T + D: median 18.7 months
Pla + T + D: median 12.4 months
Δ 6.3
months
HR 0.68
95% CI = 0.58, 0.80
p < 0.0001
Swain S, NEJM 2015
1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...60
Powered by FlippingBook